Treatment of chronic obstructive pulmonary disease with nebulized beta 2-agonist or combined nebulized beta 2-agonist and anticholinergic administration

摘要

#$%^&*AU2018200965A120180301.pdf#####ABSTRACT Inhalation solutions for administration of beta 2-agonists or combinations of muscarinic antagonists and beta 2-agonists for the treatment of breathing disorders, such as COPD, 5 are provided. The inhalation solutions are administered by nebulization, particularly with a high efficiency nebulizer.